| Financial Year |
March 31 2023 |
| Monetary Funds |
1,305,062,455.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
670,860,601.19 |
| Accounts Receivable |
1,936,145,732.17 |
| Advances to Suppliers |
962,824,550.96 |
| Other Receivables |
136,191,700.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,583,190,451.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
152,175,139.75 |
| Total Current Assets |
10,754,179,869.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,123,478.32 |
| Fixed Assetes |
1,242,400,001.70 |
| Under-construction Projects |
39,814,127.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
181,046,819.08 |
| R&D expenses |
126,189,212.24 |
| Goodwill |
75,282,572.61 |
| Long-Term Deferred and Prepaid Expenses |
3,544,853.06 |
| Deferred Income Tax Assets |
81,877,113.31 |
| Other Non-Current Assets |
35,025,600.40 |
| Sub-Total of Non-Current Assets |
1,859,431,429.41 |
| Total Assets |
12,613,611,298.64 |
| Short-Term Loans |
827,721,140.70 |
| Trading Financial liabilities |
462,033,112.54 |
| Notes Payable |
-- |
| Accounts Payable |
875,207,972.50 |
| Accounts Received In Advance |
8,915,305.41 |
| Employee Compensation Payable |
60,315,717.19 |
| Taxes Payable |
80,572,573.91 |
| Interest Payable |
-- |
| Dividend Payable |
6,871,134.53 |
| Other payables |
413,462,419.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
609,787,865.57 |
| Other Current Liabilities |
150,509,214.41 |
| Sub-Total of Current Liabilities |
3,955,357,090.51 |
| Long-term Loans |
1,610,390,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
119,830,871.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,861,299.49 |
| Deferred Income Tax Liabilities |
13,257,494.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,271,694,569.40 |
| Total Liabilities |
6,227,051,659.91 |
| Paid-In Capital(Or Share Stock) |
761,067,590.00 |
| Capital Surplus |
4,477,188,244.94 |
| Surplus Reserve |
150,252,245.30 |
| LESS:Treasury Stock |
254,789,561.15 |
| Undistributed Profits |
979,595,547.47 |
| Minority Stockholder's Interest |
260,655,808.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,125,903,829.91 |
| Owner's Equity（Stockholder's Equity） |
6,386,559,638.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,613,611,298.64 |
